The WHO has published the COVID-19 vaccines: safety surveillance manual to guide the processes for collecting, analysing and sharing safety data and information on COVID-19 vaccines within and across countries. To accompany this manual and facilitate the conduct of active safety surveillance studies using harmonized tools and methods, a protocol template for cohort event monitoring (CEM) studies has been developed. Read more about development of the protocol template, the cohort event monitoring (CEM) study design, and how it can identify previously unrecognised and unsuspected adverse reactions to the vaccine. The CEM protocol was commissioned by World Health Organization (WHO), coordinated by Dr. Christine Guillard with the support of Dr. Noha Iessa, in the Pharmacovigilance (PVG) team, within the Regulation and Prequalification department at WHO Headquarters.
- The UK Expert Haematology Panel (EHP) has produced guidance on the syndrome of Thrombosis and Thrombocytopenia occurring after coronavirus vaccination April 8, 2021
- Why is it so hard to investigate the rare side effects of COVID vaccines? April 7, 2021
- Protocol template for cohort event monitoring (CEM) for safety signal detection after vaccination with COVID-19 vaccines March 30, 2021
- COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets March 20, 2021
- Vaccine safety experience updates from the US CDCs Vaccine Safety Technical Subgroup (VaST) March 17, 2021